Position in OMER
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$300,432
+$206,801 QoQ
Shares Held
28,450
+422.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Derivatives in OMER
reported options exposure · as of Dec 31, 2025CallValue
$343,600
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vontobel Holding Ltd. holds $92,341,956 across 47 Biotechnology names. OMER ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
83,380 | $37,232,503 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,794 | $22,247,395 | |
| 3 | MRNA |
Moderna, Inc.
|
163,422 | $8,301,837 | |
| 4 | BNTX |
BioNTech SE
|
93,107 | $8,275,350 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,476 | $1,811,842 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
17,872 | $1,327,174 | |
| 7 | MCRB |
Seres Therapeutics, Inc.
|
138,468 | $1,228,211 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
135,605 | $1,148,574 |
All Filings in OMER
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $300,432 | 28,450 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $93,631 | 5,450 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $343,600 | 20,000 | Call | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||